Skip to content

ROLE OF RASAPACHAK POWDER IN HYPOTHYROIDISM

ADD ON EFFICACY OF RASAPACHAK CHURNA IN HYPOTHYROIDISM-A SINGLE ARM CLINICAL STUDY

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041141
Enrollment
30
Registered
2022-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Sponsors

Dr Shrikrishna Gawankar
Lead Sponsor
Dr Mrudula Joshi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having lowered T3 and T4 values. 2. T3, T4 normal Sr. TSH mildly raised. 3. Patients having symptoms like fatigue/somnolence, anaemia, aches and pain, dry and flaky skin, early greying and falling of hair.

Exclusion criteria

Exclusion criteria: autoimmune and genetic disorders

Design outcomes

Primary

MeasureTime frame
Rasapachak Churna is effective in HypothyrodismTimepoint: 30 days study with follow ups on 7th,15th,22nd and 30th day

Secondary

MeasureTime frame
Patient clinically improved with increased quality of lifeTimepoint: 1month

Countries

India

Contacts

Public ContactDr Shrikrishna Gawankar

Dr. D. Y. Patil College of Ayurved & Research Centre, Pimpri

mrudula.doctor@gmail.com9226279270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026